REFERENCES
- Tapson VF: Acute pulmonary embolism. N Engl J Med. 2008;358:1037–1052.
- Kao SJ, Chen HI: Nitric oxide mediates acute lung injury caused by fat embolism in isolated rat's lungs. J Trauma. 2008;64:462–469.
- Yi T, Rao DA, Tang PC, Cuchara LA, Bothwell AL, Colangelo CM, Tellides G, Pober JS, Lorber MI: Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells. Transplantation. 2008;86:719–727.
- Okopien B, Krysiak R, Kowalski J, Madej A, Belowski D, Zielinski M, Labuzek K, Herman ZS: The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia. Atherosclerosis. 2004;176:327–335.
- Weis M, Pehlivanli S, Meiser BM, von Scheidt W: Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. Am Coll Cardiol. 2001;38:814–818.
- Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC, Semprini MC, Gerlach RF, Cunha FQ, Tanus-Santos JE: Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. Crit Care Med. 2007;35:239–245.
- Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE: Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. Eur J Pharmacol. 2004;498:189–194.
- Li YB, Liang MT, Yang Y, Hou XH, Kong JB, Xu JL, Wang LX: Impact of acute pulmonary embolism on plasma and tissue hepatocyte growth factor: an experimental study. Exp Lung Res. 2010;36:237–242.
- Eagleton MJ, Henke PK, Luke CE, Hawley AE, Bedi A, Knipp BS, Wakefield TW, Greenfield LJ: Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg. 2002;36:581–588.
- Tsang J, Simon M, Stewart K, Qayumi K, Battistini B: Proinflammatory cytokines are not released in the circulation following acute pulmonary thromboembolism in pigs. J Invest Surg. 2002;15:29–35.
- Tuomisto TT, Lumivuori H, Kansanen E, Hakkinen SK, Turunen MP, van Thienen JV, Horrevoets AJ, Levonen AL, Yla-Herttuala S: Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc Res. 2008;78:175–184.
- Palei AC, Zaneti RA, Fortuna GM, Gerlach RF, Tanus-Santos JE: Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology. 2005;56:611–617.
- Fortuna GM, Figueiredo-Lopes L, Dias-Junior CA, Gerlach RF, Tanus-Santos JE: A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. Int J Cardiol. 2007;114:22–27.
- Dias-Junior CA, Cau SB, Oliveira AM, Castro MM, Montenegro MF, Gerlach RF, Tanus-Santos JE: Nitrite or sildenafil, but not BAY 41–2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress. Thromb Res. 2009;124:349–355.
- Souza-Costa DC, Zerbini T, Palei AC, Gerlach RF, Tanus-Santos JE: l-Arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9. Chest. 2005;128:3705–710.
- Laufs U, La Fata V, Plutzky J, Liao JK: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97:1129–1135.
- Rikitake Y, Liao JK: Rho GTPases, statins, and nitric oxide. Circ Res. 2005;97:1232–1235.
- Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC, Semprini MC, Gerlach RF, Cunha FQ, Tanus-Santos JE: Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. Crit Care Med. 2007;35:239–245.